These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 27465283)

  • 1. A case of hereditary coproporphyria precipitated by efavirenz.
    Grimes R; Gilleece Y; Appleby T; Stockwell S; Pinto-Sander N; Sahabandu T; Stein P; Bradshaw D
    AIDS; 2016 Aug; 30(13):2142-3. PubMed ID: 27465283
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute porphyria precipitated by efavirenz.
    Pavitt CW; Rampling T; Byrne R; Tyebally S; Reid T; Nelson M
    AIDS; 2015 May; 29(8):981-2. PubMed ID: 25909830
    [No Abstract]   [Full Text] [Related]  

  • 3. Vitamin D deficiency in HIV-infected patients: associated with non-nucleoside reverse transcriptase inhibitor or efavirenz use?
    Pasquet A; Viget N; Ajana F; de la Tribonniere X; Dubus S; Paccou J; Legroux-Gérot I; Melliez H; Cortet B; Yazdanpanah Y
    AIDS; 2011 Mar; 25(6):873-4. PubMed ID: 21412064
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-HIV agents. Efavirenz and fat wasting--what might be happening?
    TreatmentUpdate; 2007 Feb; 19(2):7-8. PubMed ID: 17447315
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuropsychiatric symptoms associated with efavirenz: prevalence, correlates, and management. A neurobehavioral review.
    Muñoz-Moreno JA; Fumaz CR; Ferrer MJ; González-García M; Moltó J; Negredo E; Clotet B
    AIDS Rev; 2009; 11(2):103-9. PubMed ID: 19529750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-HIV agents. A second study confirms fat loss issues with efavirenz.
    TreatmentUpdate; 2007 Feb; 19(2):6-7. PubMed ID: 17447314
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-HIV agents. American study finds efavirenz linked to fat wasting.
    TreatmentUpdate; 2007 Feb; 19(2):4-6. PubMed ID: 17447313
    [No Abstract]   [Full Text] [Related]  

  • 8. Efavirenz urolithiasis.
    Izzedine H; Valantin MA; Daudon M; Mohand HA; Caby F; Katlama C
    AIDS; 2007 Sep; 21(14):1992. PubMed ID: 17721118
    [No Abstract]   [Full Text] [Related]  

  • 9. Efavirenz and psychosis: is there a link?
    Manning TG
    Aust N Z J Psychiatry; 2012 Jul; 46(7):687-8. PubMed ID: 22735641
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study.
    ; Carey D; Puls R; Amin J; Losso M; Phanupak P; Foulkes S; Mohapi L; Crabtree-Ramirez B; Jessen H; Kumar S; Winston A; Lee MP; Belloso W; Cooper DA; Emery S
    Lancet Infect Dis; 2015 Jul; 15(7):793-802. PubMed ID: 25877963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired sperm motility in HIV-infected men: an unexpected adverse effect of efavirenz?
    Frapsauce C; Grabar S; Leruez-Ville M; Launay O; Sogni P; Gayet V; Viard JP; De Almeida M; Jouannet P; Dulioust E
    Hum Reprod; 2015 Aug; 30(8):1797-806. PubMed ID: 26085581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efavirenz-Associated Urinary Matrix Stone-A Rare Presentation.
    Khalil C; Mohanty MJ; Kaatz G; Abu-Hamdan D
    Am J Med Sci; 2016 Feb; 351(2):213-4. PubMed ID: 26897279
    [No Abstract]   [Full Text] [Related]  

  • 13. Haem arginate as effective maintenance therapy for hereditary coproporphyria.
    Ma E; Mar V; Varigos G; Nicoll A; Ross G
    Australas J Dermatol; 2011 May; 52(2):135-8. PubMed ID: 21605099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced Effectiveness of Contraceptive Implants for Women Taking the Antiretroviral Efavirenz (EFV): Still Good Enough and for How Long?
    Shelton JD
    Glob Health Sci Pract; 2015 Dec; 3(4):528-31. PubMed ID: 26681700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment. Study suggests efavirenz may damage brain cells.
    AIDS Policy Law; 2012 Nov; 28(1):1. PubMed ID: 23259163
    [No Abstract]   [Full Text] [Related]  

  • 16. The Rise and Fall of Efavirenz.
    Cluck D; Lewis P; Durham SH; Hester EK
    J Int Assoc Provid AIDS Care; 2016 May; 15(3):181-3. PubMed ID: 26858315
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute psychosis under efavirenz in a HIV patient.
    Zalila H; Elloumi H; Gaha N; Ghachem R; Ghazali I; Boussetta A
    Tunis Med; 2010 Feb; 88(2):119-21. PubMed ID: 20415173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team.
    Staszewski S; Morales-Ramirez J; Tashima KT; Rachlis A; Skiest D; Stanford J; Stryker R; Johnson P; Labriola DF; Farina D; Manion DJ; Ruiz NM
    N Engl J Med; 1999 Dec; 341(25):1865-73. PubMed ID: 10601505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two cases of successful efavirenz desensitization in patients with several anti-HIV drugs hypersensitivities.
    D'Erme AM; Severino M; Tiradritti L; Testi S; Tchoimou T; Bertelli A; Zuccati G; Gola M
    G Ital Dermatol Venereol; 2015 Aug; 150(4):476-8. PubMed ID: 26224235
    [No Abstract]   [Full Text] [Related]  

  • 20. Lipid metabolism and lipodystrophy in HIV-1-infected patients: the role played by nonnucleoside reverse transcriptase inhibitors.
    Sension M; Deckx H
    AIDS Rev; 2015; 17(1):21-36. PubMed ID: 25472015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.